Search results
Incyte (INCY) to Report Q1 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 3 weeks agoIncyte's (INCY) first-quarter 2024 revenues are likely to have been driven by the U.S. sales and...
INCY vs. TECH: Which Stock Should Value Investors Buy Now?
Zacks via Yahoo Finance· 2 years agoInvestors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both...
INCY vs. GMAB: Which Stock Is the Better Value Option?
Zacks via Yahoo Finance· 2 years agoInvestors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both...
Unveiling Incyte (INCY)'s Value: Is It Really Priced Right? A Comprehensive Guide
GuruFocus.com via Yahoo Finance· 7 months agoIncyte Corp (NASDAQ:INCY) experienced a daily gain of 0.89% and a 3-month loss of -6.29%. The...
Incyte (INCY) is a Great Momentum Stock: Should You Buy?
Zacks via Yahoo Finance· 1 year agoMomentum investing is all about the idea of following a stock's recent trend, which can be in either...
Incyte (INCY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Zacks via Yahoo Finance· 1 year agoIncyte (INCY) possesses the right combination of the two key ingredients for a likely earnings beat...
Incyte (INCY) Outperforms YTD: Will the Momentum Continue?
Zacks via Yahoo Finance· 1 year agoShares of Incyte INCY have gained 5.9% in the year so far against the industry’s decline of 19.7%....
Incyte (INCY) Q2 Earnings and Revenues Surpass Estimates
Zacks via Yahoo Finance· 2 years agoIncyte (INCY) delivered earnings and revenue surprises of 27.85% and 11.04%, respectively, for the...
Incyte's (INCY) Q4 Earnings & Revenues Fall Shy of Estimates
Zacks via Yahoo Finance· 3 months agoIncyte's (INCY) fourth-quarter 2023 earnings and revenues miss estimates. Quarterly revenues cross...
Incyte (INCY) Gets FDA Nod for Label Expansion of Pemazyre
Zacks via Yahoo Finance· 2 years agoIncyte (INCY) obtains FDA approval for Pemazyre for a second indication - the treatment of adults...